326 related articles for article (PubMed ID: 21323814)
1. Immune intervention for type 1 diabetes mellitus.
Skyler JS
Int J Clin Pract Suppl; 2011 Feb; (170):61-70. PubMed ID: 21323814
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation for type 1 diabetes mellitus.
Skyler JS
Int J Clin Pract Suppl; 2010 Feb; (166):59-63. PubMed ID: 20377666
[TBL] [Abstract][Full Text] [Related]
3. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
4. Prediction and prevention of type 1 diabetes: progress, problems, and prospects.
Skyler JS
Clin Pharmacol Ther; 2007 May; 81(5):768-71. PubMed ID: 17392722
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune disorders in diabetes.
Boitard C; Debray-Sachs M; Bach JF
Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
[TBL] [Abstract][Full Text] [Related]
6. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model.
Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ
Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153
[TBL] [Abstract][Full Text] [Related]
7. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
[TBL] [Abstract][Full Text] [Related]
8. Diabetogenic T lymphocytes in human Type 1 diabetes.
Roep BO; Peakman M
Curr Opin Immunol; 2011 Dec; 23(6):746-53. PubMed ID: 22051340
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.
Phillips BE; Giannoukakis N; Trucco M
Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.
Nikolic T; Welzen-Coppens JM; Leenen PJ; Drexhage HA; Versnel MA
Immunobiology; 2009; 214(9-10):791-9. PubMed ID: 19628297
[TBL] [Abstract][Full Text] [Related]
11. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
12. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
13. CD8+ T cells in type 1 diabetes.
Tsai S; Shameli A; Santamaria P
Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164
[TBL] [Abstract][Full Text] [Related]
14. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes.
Silveira PA; Grey ST
Trends Endocrinol Metab; 2006; 17(4):128-35. PubMed ID: 16580840
[TBL] [Abstract][Full Text] [Related]
15. Therapies aimed at preservation or restoration of beta cell function in type 1 diabetes.
Keymeulen B
Verh K Acad Geneeskd Belg; 2008; 70(2):85-103. PubMed ID: 18630722
[TBL] [Abstract][Full Text] [Related]
16. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
Hummel M; Durinovic-Bello I; Ziegler AG
J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
[TBL] [Abstract][Full Text] [Related]
17. Immunological aspects of diabetes.
Cheţa D
Recenti Prog Med; 1990 Feb; 81(2):72-8. PubMed ID: 2195611
[TBL] [Abstract][Full Text] [Related]
18. [New findings on the pathogenesis of diabetes mellitus].
Keller U
Schweiz Med Wochenschr; 1986 Jan; 116(3):66-71. PubMed ID: 3511524
[TBL] [Abstract][Full Text] [Related]
19. [Autoimmunity and insulin-dependent diabetes mellitus. Experimental data and therapeutic prospects].
Thivolet C; Khallouf E
Pediatrie; 1989; 44(4):247-57. PubMed ID: 2677968
[TBL] [Abstract][Full Text] [Related]
20. Immunological disorders of type 1 diabetes mellitus.
Ziegler M; Ziegler B
Exp Clin Endocrinol; 1989 Sep; 94(1-2):97-114. PubMed ID: 2689194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]